Telmisartan Benzimidazole Asid CAS 152628-03-0 Pite> 99.5% (HPLC) Telmisartan Entèmedyè 3 Faktori
Ruifu Chimik Pwovizyon pou Telmisartan Entèmedyè ak Pite segondè
Telmisartan CAS 144701-48-4
Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8
2-(p-Tolyl) asid benzoik CAS 7148-03-0
Telmisartan Benzimidazole Asid CAS 152628-03-0
Telmisartan Methyl Ester CAS 528560-93-2
Methyl 2-[4-(Bromethyl)phenyl]benzoate CAS 114772-38-2
Methyl 4-(Butyrylamino)-3-Methyl-5-Nitrobenzoate CAS 152628-01-8
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole CAS 152628-02-9
Non Chimik | 4-Methyl-2-Propyl-6-Benzimidazolecarboxylic Asid |
Sinonim | Telmisartan Benzimidazol Asid;Telmisartan Entèmedyè 3;4-Methyl-2-n-Propyl-1H-Benzimidazole-6-Carboxylic Asid;2-n-Propyl-4-Methyl-6-Carboxylate-1H-Benzimidazol;1H-Benzimidazole-4-Methyl-2-Propyl-6-Carboxylic Asid;7-Methyl-2-Propyl-1H-Benzimidazole-5-Carboxylic Asid |
Nimewo CAS | 152628-03-0 |
Nimewo CAT | RF-PI1880 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C12H14N2O2 |
Pwa molekilè | 218.26 |
Pwen k ap fonn | 300℃ (lit.) |
Dansite | 1.259±0.06 g/cm3 |
Solibilite | Soluble nan DMSO ak Methanol |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan pou blan |
Idantifikasyon (HPLC) | Dwe konfòme ak estanda referans |
Pite / Metòd analiz | >99.5% (HPLC) |
Dlo (pa Karl Fischer) | <0.50% |
Rezid sou ignisyon | <0.20% |
Nenpòt sèl enpurte | <0.50% |
Enpurte total | <0.50% |
Metal lou | <20ppm |
Spectre proton RMN | Konfòm ak estrikti |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Telmisartan (CAS: 144701-48-4) |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
4-Methyl-2-Propyl-6-Benzimidazolecarboxylic Asid, konnen tou kòm Telmisartan Benzimidazole Acid (CAS: 152628-03-0) se yon entèmedyè enpòtan nan Telmisartan (CAS: 144701-48-4).Telmisartan se yon antagonist reseptè anjyotansin ki pisan, ki dire lontan, ki pa peptide AT1endike pou: Tretman tansyon wo, pou bese tansyon.Bese tansyon diminye risk pou evènman kadyovaskilè fatal ak ki pa fatal, sitou kou ak enfaktis myokad.Rediksyon risk kadyovaskilè (CV) nan pasyan ki pa kapab pran inibitè ACE.Itilize pou kont li oswa nan konbinezon ak lòt klas nan antihypertensives pou tretman tansyon wo.Yo itilize tou nan tretman nefropati dyabetik nan pasyan ipètansif ki gen dyabèt tip 2, osi byen ke tretman nan kè konjestif.